About this trial
The OBPM\_HARMONY study will enroll a minimum of 300 participants at the CHUV site in Lausanne, Switzerland. Each participant will complete two study visits at CHUV, scheduled at least 24.5 hours apart. Between these visits, participants will be asked to wear both the Hilo band, an Ambulatory Blood Pressure Monitor (ABPM) as well as a hydrostatic pressure system continuously for a 24-hour period.
Eligibility criteria
Qualifiers
Subjects aged 21 to 85yo
Subjects fluent in written and spoken French, capable of discernment
Subjects agreeing to attend the two study visits and follow study procedures
Subjects residing within 100 km of the CHUV site
Disqualifiers
Damaged/injured skin at the right wrist
Subjects with tachycardia (heart rate at rest > 120bpm)
Subjects with atrial fibrillation
Subjects with diabetes
Trial design
Treatments tested in this trial
- Wearing Hilo band, Ambulatory Blood Pressure Monitor, and Hydrostatic Pressure monitor